Vera Therapeutics VERA Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's total liabilities & equity?
- Vera Therapeutics (VERA) reported total liabilities & equity of $621.74M in Q1 2026.
- How has Vera Therapeutics's total liabilities & equity changed year-over-year?
- Vera Therapeutics's total liabilities & equity increased by 1.9% year-over-year, from $610.17M to $621.74M.
- What is the long-term trend for Vera Therapeutics's total liabilities & equity?
- Over 5 years (2020 to 2025), Vera Therapeutics's total liabilities & equity has grown at a 68.2% compound annual growth rate (CAGR), from $54.55M to $734.73M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.